Kat5 Protein — Lysine Acetyltransferase 5 (Tip60) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| KAT5 Protein | |
|---|---|
| Protein Name | Lysine Acetyltransferase 5 (TIP60) |
| Gene | KAT5 |
| UniProt ID | Q9Y5X4 |
| Molecular Weight | 60 kDa |
| Subcellular Localization | Nucleus, Cytoplasm |
| Protein Family | MYST family of histone acetyltransferases |
KAT5 (TIP60) is a member of the MYST family of histone acetyltransferases. It contains a catalytic HAT domain and a chromodomain that recognizes methylated histones. KAT5 functions as part of the TIP60 complex, which includes multiple subunits that regulate its activity and targeting.
KAT5 acetylates histone H2A (particularly on lysine 5) and histone H4. It functions as a transcriptional coactivator and is involved in:
In neurons, KAT5 plays important roles in:
The study of Kat5 Protein — Lysine Acetyltransferase 5 (Tip60) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The KAT5 Protein is involved in various cellular processes in the nervous system. This protein plays important roles in neuronal function, ion channel regulation, and cellular homeostasis. Dysfunction has been implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and related disorders.
The KAT5 Protein participates in multiple molecular pathways critical for neuronal health. It is expressed in various brain regions and cell types, where it contributes to synaptic transmission, membrane potential regulation, and intracellular signaling.
Alterations in KAT5 Protein expression or function have been associated with several neurodegenerative conditions. Research suggests this protein may serve as a therapeutic target for disease modification.